Animalcare Group Past Earnings Performance
Past criteria checks 4/6
Animalcare Group has been growing earnings at an average annual rate of 68.1%, while the Pharmaceuticals industry saw earnings declining at 5.2% annually. Revenues have been growing at an average rate of 0.6% per year. Animalcare Group's return on equity is 4.8%, and it has net margins of 6.1%.
Key information
68.1%
Earnings growth rate
68.1%
EPS growth rate
Pharmaceuticals Industry Growth | 14.1% |
Revenue growth rate | 0.6% |
Return on equity | 4.8% |
Net Margin | 6.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Animalcare Group's (LON:ANCR) Dividend Will Be Increased To £0.03
Jun 16Animalcare Group (LON:ANCR) Is Paying Out A Larger Dividend Than Last Year
May 29Animalcare Group (LON:ANCR) Is Increasing Its Dividend To £0.03
Apr 23Further Upside For Animalcare Group plc (LON:ANCR) Shares Could Introduce Price Risks After 26% Bounce
Feb 29Even With A 26% Surge, Cautious Investors Are Not Rewarding Animalcare Group plc's (LON:ANCR) Performance Completely
Feb 29Animalcare Group (LON:ANCR) Is Due To Pay A Dividend Of £0.02
Oct 13Estimating The Intrinsic Value Of Animalcare Group plc (LON:ANCR)
Jan 14Animalcare Group (LON:ANCR) Has Announced A Dividend Of £0.02
Oct 18Animalcare Group (LON:ANCR) Has Affirmed Its Dividend Of £0.02
Sep 30Estimating The Intrinsic Value Of Animalcare Group plc (LON:ANCR)
Sep 28Is There An Opportunity With Animalcare Group plc's (LON:ANCR) 20% Undervaluation?
Jun 21Animalcare Group's (LON:ANCR) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Animalcare Group (LON:ANCR) Will Pay A Larger Dividend Than Last Year At UK£0.024
Apr 28Animalcare Group's (LON:ANCR) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 01Animalcare Group (LON:ANCR) Is Due To Pay A Dividend Of UK£0.02
Oct 01Animalcare Group plc (LON:ANCR) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 08We Like These Underlying Return On Capital Trends At Animalcare Group (LON:ANCR)
Jul 10Is Animalcare Group plc (LON:ANCR) A Risky Dividend Stock?
May 10Animalcare Group (LON:ANCR) Has A Pretty Healthy Balance Sheet
Apr 19Animalcare Group (LON:ANCR) Is Reinvesting At Lower Rates Of Return
Mar 29An Intrinsic Calculation For Animalcare Group plc (LON:ANCR) Suggests It's 43% Undervalued
Mar 07If You Had Bought Animalcare Group's (LON:ANCR) Shares Three Years Ago You Would Be Down 27%
Feb 14Revenue & Expenses Breakdown
How Animalcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 76 | 5 | 36 | 3 |
31 Mar 24 | 75 | 3 | 35 | 3 |
31 Dec 23 | 74 | 1 | 35 | 3 |
30 Sep 23 | 71 | 1 | 33 | 3 |
30 Jun 23 | 69 | 1 | 32 | 3 |
31 Mar 23 | 70 | 2 | 32 | 3 |
31 Dec 22 | 72 | 2 | 32 | 3 |
30 Sep 22 | 72 | 2 | 32 | 3 |
30 Jun 22 | 73 | 2 | 31 | 3 |
31 Mar 22 | 74 | 1 | 31 | 3 |
31 Dec 21 | 74 | 0 | 31 | 3 |
30 Sep 21 | 75 | 0 | 31 | 3 |
30 Jun 21 | 75 | 0 | 32 | 4 |
31 Mar 21 | 73 | 0 | 31 | 4 |
31 Dec 20 | 70 | 0 | 30 | 3 |
30 Sep 20 | 70 | 0 | 30 | 4 |
30 Jun 20 | 70 | 1 | 29 | 4 |
31 Mar 20 | 70 | 0 | 29 | 4 |
31 Dec 19 | 71 | -1 | 29 | 4 |
30 Sep 19 | 72 | -2 | 29 | 4 |
30 Jun 19 | 73 | -3 | 29 | 5 |
31 Mar 19 | 73 | -1 | 29 | 5 |
31 Dec 18 | 72 | 0 | 29 | 5 |
30 Sep 18 | 72 | 0 | 30 | 4 |
30 Jun 18 | 72 | 0 | 30 | 4 |
31 Mar 18 | 67 | 0 | 28 | 3 |
31 Dec 17 | 62 | 0 | 26 | 3 |
31 Dec 16 | 68 | 4 | 22 | 2 |
31 Dec 15 | 47 | -1 | 15 | 1 |
31 Dec 14 | 34 | 1 | 8 | 0 |
Quality Earnings: ANCR has a large one-off gain of £2.3M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: ANCR's current net profit margins (6.1%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ANCR has become profitable over the past 5 years, growing earnings by 68.1% per year.
Accelerating Growth: ANCR's earnings growth over the past year (275.5%) exceeds its 5-year average (68.1% per year).
Earnings vs Industry: ANCR earnings growth over the past year (275.5%) exceeded the Pharmaceuticals industry 9.5%.
Return on Equity
High ROE: ANCR's Return on Equity (4.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/20 12:23 |
End of Day Share Price | 2025/01/17 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Animalcare Group plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Seb Jantet | Panmure Liberum |
Max Herrmann | Stifel, Equities Research |
James Orsborne | Stifel, Equities Research |